
### [NCIT:C45625](http://purl.obolibrary.org/obo/NCIT_C45625)
**Label:** Malignant Lung and Pleural Neoplasm

**Subclasses:** [NCIT:C45627](http://purl.obolibrary.org/obo/NCIT_C45627) (Type II Pleuropulmonary Blastoma), [NCIT:C45626](http://purl.obolibrary.org/obo/NCIT_C45626) (Type I Pleuropulmonary Blastoma), [NCIT:C5669](http://purl.obolibrary.org/obo/NCIT_C5669) (Pleuropulmonary Blastoma), [NCIT:C45628](http://purl.obolibrary.org/obo/NCIT_C45628) (Type III Pleuropulmonary Blastoma), 

**Class expressions from DL-Learner:**

- [UBERON:0002402](http://purl.obolibrary.org/obo/UBERON_0002402) (pleural cavity) 57.14%
- [UBERON:0002224](http://purl.obolibrary.org/obo/UBERON_0002224) (thoracic cavity) 57.14%
- Thing 52.69%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) 42.50%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) and (not ([NCIT:C36713](http://purl.obolibrary.org/obo/NCIT_C36713) (p230 Fusion Protein Expression))) 42.50%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) and (not ([NCIT:C36712](http://purl.obolibrary.org/obo/NCIT_C36712) (p210 Fusion Protein Expression))) 42.50%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) and (not ([NCIT:C36711](http://purl.obolibrary.org/obo/NCIT_C36711) (ATIC-ALK Fusion Protein Expression))) 42.50%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) and (not ([NCIT:C36708](http://purl.obolibrary.org/obo/NCIT_C36708) (TFG-ALK Fusion Protein Expression))) 42.50%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) and (not ([NCIT:C36707](http://purl.obolibrary.org/obo/NCIT_C36707) (TPM3-ALK Fusion Protein Expression))) 42.50%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) and (not ([NCIT:C36706](http://purl.obolibrary.org/obo/NCIT_C36706) (NPM-ALK Fusion Protein Expression))) 42.50%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) and (not ([NCIT:C36704](http://purl.obolibrary.org/obo/NCIT_C36704) (FHIT Gene Inactivation))) 42.50%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) and (not ([NCIT:C36703](http://purl.obolibrary.org/obo/NCIT_C36703) (PMS2 Gene Inactivation))) 42.50%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) and (not ([NCIT:C36702](http://purl.obolibrary.org/obo/NCIT_C36702) (PMS1 Gene Inactivation))) 42.50%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) and (not ([NCIT:C36701](http://purl.obolibrary.org/obo/NCIT_C36701) (MSH6 Gene Inactivation))) 42.50%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) and (not ([NCIT:C36698](http://purl.obolibrary.org/obo/NCIT_C36698) (MLH1 Gene Inactivation))) 42.50%


